{
    "code": "52027405",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027405",
    "time": "2023-03-03 03:38:22",
    "許可證字號": "衛部藥輸字第027405號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/03\/14",
    "發證日期": "107\/03\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202740507",
    "中文品名": "左雷尼濃縮注射液4毫克\/5毫升",
    "英文品名": "Zoledronic Acid Teva Concentrate for Solution for Infusion 4mg\/5ml",
    "適應症": "•與標準癌症治療併用，適用於多發性骨髓瘤及固體腫瘤併有骨骼轉移之病人。用於攝護腺癌病人之骨骼轉移時，應至少接受過一種荷爾蒙治療而仍持續惡化者。•治療惡性腫瘤之高血鈣併發症（HCM）。",
    "劑型": "279注射液",
    "包裝": "5毫升玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥",
    "監視期限": "",
    "主成分略述": "ZOLEDRONIC ACID",
    "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
    "申請商名稱": "620102K944  香港商梯瓦藥業有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝東路二段116號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "FHR0002100  PLIVA CROATIA LTD.",
            "製造廠廠址": "PRILAZ BARUNA FILIPOVICA 25, 10000 ZAGREB, CROATIA",
            "製造廠公司地址": "",
            "製造廠國別": "CROATIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001600",
            "成分名稱": "ZOLEDRONIC ACID",
            "含量描述": "(as Zoledronic Acid Monohydrate.....4.264mg)",
            "含量": "4.0000000000",
            "單位": "MG"
        }
    ]
}